Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Revista Espanola De Salud Publica
|
June 17, 2025
[Poliomyelitis in Spain: from the past to the present, a continuous challenge]
Pedro Gullón Tosio, Cristina Guijarro Castro
Revista Espanola De Salud Publica
|
September 4, 2025
[Brain health as a global priority]
Cristina Guijarro-Castro, Pilar Aparicio-Azcárraga
Revista Espanola De Salud Publica
|
October 24, 2025
[Artificial Intelligence. Latin american perspective: interoperability and environmental effect]
Cristina Guijarro-Castro, Gabriel Omar Quispe Munayco
Revista Espanola De Salud Publica
|
April 3, 2025
[The unremitting threat: enterovirus D68, acute flaccid myelitis, and epidemiological surveillance]
Cristina Guijarro-Castro, María Cabrerizo Sanz, Josefa Masa Calles
European Journal of Neurology
|
May 5, 2022
Neuropalliative care in times of war
Katarina Rukavina, David J Oliver, Cristina Guijarro-Castro, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
May 20, 2022
Seizures and COVID-19: Results from the Spanish Society of Neurology's COVID-19 registry
Santiago Fernández Fernández, Javier Ricardo Pérez Sánchez, Guillermo Hernández Pérez, et al.
Journal of the Neurological Sciences
|
February 26, 2021
Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry
David García-Azorín, María José Abenza Abildúa, María Elena Erro Aguirre, et al.
Revista Espanola De Salud Publica
|
June 18, 2025
[Guide of recommendations for the diagnosis and neurorrehabilitative treatment of post-poliomielytic sequelar conditions]
Mónica Povedano Pandés, Ricard Rojas García, Luis Querol Gutiérrez, et al.
BMC Neurology
|
July 13, 2013
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers
Delicias Muñoz, Antonio Escartín, Dolores Dapena, et al.
Plos One
|
May 10, 2013
Candidate gene study of TRAIL and TRAIL receptors: association with response to interferon beta therapy in multiple sclerosis patients
Carlos López-Gómez, Almudena Pino-Ángeles, Teresa Órpez-Zafra, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Revista Espanola De Salud Publica
|
June 17, 2025
[Poliomyelitis in Spain: from the past to the present, a continuous challenge]
Pedro Gullón Tosio, Cristina Guijarro Castro
Revista Espanola De Salud Publica
|
September 4, 2025
[Brain health as a global priority]
Cristina Guijarro-Castro, Pilar Aparicio-Azcárraga
Revista Espanola De Salud Publica
|
October 24, 2025
[Artificial Intelligence. Latin american perspective: interoperability and environmental effect]
Cristina Guijarro-Castro, Gabriel Omar Quispe Munayco
Revista Espanola De Salud Publica
|
April 3, 2025
[The unremitting threat: enterovirus D68, acute flaccid myelitis, and epidemiological surveillance]
Cristina Guijarro-Castro, María Cabrerizo Sanz, Josefa Masa Calles
European Journal of Neurology
|
May 5, 2022
Neuropalliative care in times of war
Katarina Rukavina, David J Oliver, Cristina Guijarro-Castro, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
May 20, 2022
Seizures and COVID-19: Results from the Spanish Society of Neurology's COVID-19 registry
Santiago Fernández Fernández, Javier Ricardo Pérez Sánchez, Guillermo Hernández Pérez, et al.
Journal of the Neurological Sciences
|
February 26, 2021
Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry
David García-Azorín, María José Abenza Abildúa, María Elena Erro Aguirre, et al.
Revista Espanola De Salud Publica
|
June 18, 2025
[Guide of recommendations for the diagnosis and neurorrehabilitative treatment of post-poliomielytic sequelar conditions]
Mónica Povedano Pandés, Ricard Rojas García, Luis Querol Gutiérrez, et al.
BMC Neurology
|
July 13, 2013
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers
Delicias Muñoz, Antonio Escartín, Dolores Dapena, et al.
Plos One
|
May 10, 2013
Candidate gene study of TRAIL and TRAIL receptors: association with response to interferon beta therapy in multiple sclerosis patients
Carlos López-Gómez, Almudena Pino-Ángeles, Teresa Órpez-Zafra, et al.
Page
of 2